Asset Management One Co., Ltd. Crispr Therapeutics Ag Transaction History
Asset Management One Co., Ltd.
- $27.7 Billion
- Q3 2024
A detailed history of Asset Management One Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 35,986 shares of CRSP stock, worth $1.83 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,986
Previous 35,986
-0.0%
Holding current value
$1.83 Million
Previous $1.94 Million
13.02%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
493Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$403 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$381 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$152 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$151 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$151 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.97B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....